Clinical trial
Non-microradical Resection Margin as a Predictor for Recurrence After Complete Mesocolic Excision: a Prospective Cohort Study
NCT04395534 is registered in ClinicalTrials.gov with Claus Anders Bertelsen, PhD, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-microradical Resection Margin as a Predictor for Recurrence After Complete Mesocolic Excision: a Prospective Cohort Study
- Lead sponsor
- Claus Anders Bertelsen, PhD, MD
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2008
- Completion date
- March 15, 2020
- Enrollment
- 276 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
colon cancer